OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treatedLAWRENCEVILLE, N.J., Sept (GLOBE ...

IMUNON (IMNN) announced that new translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational therapy for the treatment of ...

The medium, which is designed for high density perfusion culture, is available in a variety of media package options for continuous processing.

Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Basilard BioTech, a Southern California biotechnology company pioneering novel ...

CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies and is now expanding into solid ...

The partnership aims to create a non-viral system to expedite engineered cell therapy delivery by addressing bottlenecks.

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Cell Therapy Raw Materials Market Through 2025? There has been a significant increase ...

Plasmids (pTL20c_MND_WAS_650 or its variants, pTL20c_MND_GFP_400, pPGK_ble) were transformed into NEB ® Stable Competent E. coli Cells (a derivative of the DH10B strain) in LB Broth, Vegitone.

This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of traditional CAR T cell production. This innovative approach could ...

Researchers from the University of California San Diego Sanford Stem Cell Institute have discovered that spaceflight accelerates the aging of human hematopoietic stem and progenitor cells (HSPCs), ...

India's GST Council has reduced the GST rate on solar cells – whether or not assembled into modules – from 12% to 5%, effective Sept. 22. The tax cut is expected to make solar cells and modules more ...